Skip to content

OBSERVATION OF ANESTHETIC CONSUMPTION IN CANNABINOID USERS TO IMPROVE ANESTHETIC MANAGEMENT AND POSTOPERATIVE OPIATE USE

OBSERVATION OF ANESTHETIC CONSUMPTION IN CANNABINOID USERS TO IMPROVE ANESTHETIC MANAGEMENT AND POSTOPERATIVE OPIATE USE - STOICISM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036897
Enrollment
250
Registered
2025-06-26
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F12.1 F12.8

Interventions

Group 1: Patients who use cannabinoids or opiods and get an elective operation Group 2: Cannabinoid and opiate-naive patients undergoing elective surgery

Sponsors

Universitätsklinikum Münster
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients undergoing elective surgery in the fields of a) orthopaedics, b) trauma surgery, c) general surgery, d) urology, e) maxillofacial surgery or f) thoracic surgery operations

Exclusion criteria

Exclusion criteria: 1. Patients who receive epidural or spinal anesthesia 2. Patients with a chronic pain diagnosis 3. Patients who had anesthesia in the last four weeks before the current operation 4. Patients who require ICU treatment 5. Patients requiring mechanical ventilation after leaving the operation room 6. Patients who receive clonidine as medication as part of a disease 7. Patients who receive pregabalin or gabapentin or related active substances as medication in the context of a disease 8. Persons with any kind of dependency on the investigator or employed by the sponsor or investigator. 9. Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Total consumption of anesthetics (opioids, inhaled anesthetics or propofol) for induction and control of intraoperative anesthesia. Measurements in milligrams (mg) of active ingredient either by liquid medication or by vapor measurement for inhaled medications, based on body weight (mg/kg body weight or µg/kg body weight).

Secondary

MeasureTime frame
1.Postoperative pain as measured by the Numerical Rating Scale (NRS) 2.Postoperative opioid consumption 3.Intraoperative vasopressor consumption absolute and in µg/kg body weight 4.Time in the post anesthesia care unit until transfer to the normal ward 5.Intraoperative complications defined as a.Tachycardia, defined as a heart rate of more than 100 bpm b.Hypertension, defined as a blood pressure above 140/90 mmHg in 80-year-old patients c.other stress-related reactions d.Impending or actual awakening of the patient from anesthesia, characterized by eye opening, intentional or unintentional limb movements, standing up, sitting up, etc. 6. Nociceptor level index (NOL index) intraoperatively (intubation, during the course)

Countries

Germany

Contacts

Public ContactLudwig Maximilian Schöne

Universitätsklinikum Münster

ludwigmaximilian.schoene@ukmuenster.de+49 251 8347282

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026